From digital insurance to intelligent insurance: Why AI is becoming the new operating layer
Sriram Naganathan, President & CTO, HDFC ERGO General Insurance, on how AI is moving beyond automation to reshape risk…
Author
From digital adoption to intelligent execution: How operational excellence is reshaping financial…
Financial services is entering a phase where technology adoption alone is no longer enough. As customer expectations move towards…
India’s enterprise AI push moves from experimentation to production
India’s enterprise AI push is moving beyond experimentation, but the next phase of adoption will depend less on the availability…
From faster claims to smarter risk: How AI is reshaping the insurance value chain
Kayzad Hiramanek, Chief Operating Officer, Edelweiss Life Insurance, on why the next phase of insurance technology is not simply…
From technology adoption to business impact: Why enterprise transformation is entering a new phase
Enterprise technology is entering a more demanding phase. After years of heavy investment in cloud, data, AI and automation,…
The next 18 months will shape banking’s AI future: Mahesh Ramamoorthy, Yes Bank
For India’s banking sector, the AI opportunity is no longer a question of whether to adopt the technology, but where, how and how…
Leading the AI-native enterprise: Why intelligence must become the operating model
Enterprise AI has reached a defining moment. The conversation is no longer about experimenting with generative AI or launching…
Beyond digital adoption: How IndusInd Bank is engineering measurable, responsible, and scalable…
As banking steadily shifts from physical to digital, the real differentiator is no longer who adopts technology fastest—but who…
From smart factories to autonomous enterprises: Manufacturing’s next great transformation
For nearly a decade, Industry 4.0 has been synonymous with connected machines, IoT sensors, and digital transformation pilots.…
Building an AI-native pharmaceutical enterprise: Lupin’s blueprint for intelligent transformation
AI-native pharmaceutical organizations will not be defined by the number of AI models they deploy, but by their ability to create…